(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NORDIC PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

NORDIC PHARMA

ST13

US500000097219271

Class

5

Filing

97219271

Registration

8145694

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

43

Latest update

02/17/2026

Classification

Registered

Trademark type

Combined

Nice classes

5

Filing date

01/14/2022

Registration date

02/17/2026

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/17/2026

Last transaction

02/17/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/18/2024

First use in commerce

11/18/2024

Drawing code

3

Owner type

99

Owner location

Hoofddorp, NL

Examiner

CLAYTON, CHERYL A

Law office

L20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording NORDIC above PHARMA in black followed by a vertical green rectangle.

Holders and representatives

Holders

Nordic Group B.V.

Representatives

Anna Kurian Shaw HOGAN LOVELLS US LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of gynecological and obstetrical diseases and conditions

Publications

History of USPTO decisions and trademark events.

43 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/17/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

02/17/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/24/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/24/2026

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/02/2025

IUAF

USE AMENDMENT FILED

12/01/2025

EISU

TEAS STATEMENT OF USE RECEIVED

12/01/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/30/2025

EX5G

SOU EXTENSION 5 GRANTED

09/29/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/29/2025

EEXT

SOU TEAS EXTENSION RECEIVED

05/12/2025

EXT5

SOU EXTENSION 5 FILED

05/11/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/03/2025

EX4G

SOU EXTENSION 4 GRANTED

12/07/2024

EXT4

SOU EXTENSION 4 FILED

12/06/2024

EEXT

SOU TEAS EXTENSION RECEIVED

12/06/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/18/2024

EX3G

SOU EXTENSION 3 GRANTED

05/17/2024

EXT3

SOU EXTENSION 3 FILED

05/17/2024

EEXT

SOU TEAS EXTENSION RECEIVED

05/17/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/15/2023

EX2G

SOU EXTENSION 2 GRANTED

11/13/2023

EXT2

SOU EXTENSION 2 FILED

11/13/2023

EEXT

SOU TEAS EXTENSION RECEIVED

11/13/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/13/2023

EX1G

SOU EXTENSION 1 GRANTED

05/11/2023

EXT1

SOU EXTENSION 1 FILED

05/11/2023

EEXT

SOU TEAS EXTENSION RECEIVED

05/11/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/06/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/11/2022

PUBO

PUBLISHED FOR OPPOSITION

10/11/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/21/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/07/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/31/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/31/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/31/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/30/2022

GNRT

NON-FINAL ACTION E-MAILED

08/30/2022

CNRT

NON-FINAL ACTION WRITTEN

08/30/2022

DOCK

ASSIGNED TO EXAMINER

08/25/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

01/21/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/20/2022

NWAP

NEW APPLICATION ENTERED

01/18/2022

Continuous trademark protection

Get notified about every new filing that threatens NORDIC PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.